Consultancy offered for market access related services in biopharmaceutical/ medical devices markets and the NHS. I'm currently working with Exhalation Technology Ltd which will provide ground breaking technology in the respiratory field. Previously I worked with Novaris as a Patient Access Manager, a role with two hats; commercial and service related. It's great to be able to offer the NHS support in services for psoriatic arthritis, psoriasis and ankylosing spondylitis. I have also worked with OUTiCO on a variety of projects. OUTiCO are a ‘Multi-Channel’ Sales Company communicating with Health Care Professional’s via their preferred sales channel, giving more HCP access options and opportunities.

Covid testing at homes and schools

Therapy area: Atopic asthma and eczemaRecruit , manage, coach field Market Access teamKey Account ManagementSecure funding through tendering, budget impact modelling and business casesWork with agencies as necessary eg manage the NICE HTA process

Focused alignment of activites for raising awareness on Multiple MyelomaEnsuring robust clinical updates and education support to HCPs

Project management in:Market Access including strategic planning pre MA, access materials and in line marketing Service development/tenderingAccount/Project ManagementTrainingClients & ProjectsPfizer- mapping the private health market for the Speciality Care Business UnitOctopuseducation- supporting educational events for Medicines Optimisation personnel in the NHSRoche- project management and creation of market acccess materials for new biologic launch in Market Access teamMedinvent- creating market readiness for new obs/gyn device launch and planning field activityCare Oncology Clinic- sign posting new service for patients refractory to current treatmentSEEK- providing insights into payor and hospital landscape for new woundcare product launchSanofi Pasteur MSD- strategic planning and mapping landscape for new paediatric pipeline vaccines and preparing for tender readiness

RAM in the Oncology Business Unit. Delivering against market growth, sales and KPIs in addition to Key accounts include The Royal Marsden, private hospitals and NHS hospitals within set boundaries.

Key therapy areas included diabetes and cardiovascular.

Developing service models for the GPs we are in partnership with through the formation of a LLP (Limited Liability Partnership)

Tendering for business:models of care for out of hours, gp practices. respiratory service re-design, sexual health,and dental practicesSome Contract management, including PCT, Patient and Public Involvement Forums,

Production of all product and corporate marketing materials including company stand and access itemsWeb re-design for the company web siteNHS conferencing and key opinion leader development in the sterilsation fieldProducing all marketing and corporate slides with production team; video links for web and customer presentationsAdvertising campaigns in selective journals

Commenced employment as a hospital and GP representative, after which I moved into a role as Coach, NHS Liasion Manager, and Regional Business Manager. During this time I worked on organising training for the NHS teams of BIL and Pfizer and servced as the Field Force Effectiveness lead for my team for Spriva. My team and I worked with marketting on market access for Spiriva one year before launch. As a RBM, I initially managed my NHS team and then the hospital team on my territory as well.I also worked with marketting on producing and trialling the health economic model for COPD.I have worked with marketting and the extended team to create NHS brand portfolio.

clinics and hospitals; education & training in infant nutrition to nursing & paediatric staff and parents. Selling of Milupa products to hospitals, clinics, and community wholesalers.

Hoffman La Roche – August 1993 – April 1994GP/Hospital Representative – Anti depressants, NSAIDS, drugs for Parkinson’s disease, anti- fungals.GP/Hospital Representative – Nicholas Laboratories (taken over by Hoffman La Roche) – September 1991 – July 1993- Antibiotics, benzodiazepines.